The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: A phase 2 study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma.Crescens Diane Tiu,Sarah Derby,Noor Md Haris,Liam Welsh,Anna Stansfeld,Thomas Hundsberger,Patrick Roth, Fatima Konig,Joel Robert Eisner,Malte Kleinschmidt,Stephanie Anderson,Felix Bachmann,Heidi A. Lane,Marc Engelhardt,Thomas Kaindl,Karine Litherland, Alexandru C. Stan,T. R. Jeffry Evans,Elizabeth Ruth Plummer,Juanita Suzanne LopezJOURNAL OF CLINICAL ONCOLOGY（2021）引用 4|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
